先天性低促性腺激素性性腺功能减退症
Congenital hypogonadotropic hypogonadism
基本事实
- 遗传方式
- 常染色体显性、常染色体隐性、X 连锁隐性
- 发病年龄
- 婴儿期、新生儿期
相关基因 27来自下位疾病
Orphanet 未在本条目上直接标注致病基因。下表由本组所属的下位疾病汇总而来,「来源条目」列给出基因实际标注在哪一个 ORPHA 条目上。
| 基因 | 名称 | 来源条目 |
|---|---|---|
| ARNT2 | aryl hydrocarbon receptor nuclear translocator 2 | ORPHA:3157 |
| CHD7 | chromodomain helicase DNA binding protein 7 | ORPHA:138 |
| DCAF17 | DDB1 and CUL4 associated factor 17 | ORPHA:3464 |
| DMXL2 | Dmx like 2 | ORPHA:453533 |
| FGFR1 | fibroblast growth factor receptor 1 | ORPHA:3157 |
| FOXA2 | forkhead box A2 | ORPHA:95494 |
| GH1 | growth hormone 1 | ORPHA:231679 |
| GLI2 | GLI family zinc finger 2 | ORPHA:95494 |
| HESX1 | HESX homeobox 1 | ORPHA:95494 |
| LEP | leptin | ORPHA:66628 |
| LEPR | leptin receptor | ORPHA:179494 |
| LHX4 | LIM homeobox 4 | ORPHA:95494 |
| MAGEL2 | MAGE family member L2 | ORPHA:398069 |
| NR0B1 | nuclear receptor subfamily 0 group B member 1 | ORPHA:95702 |
| OTX2 | orthodenticle homeobox 2 | ORPHA:95494 |
| PCSK1 | proprotein convertase subtilisin/kexin type 1 | ORPHA:71528 |
| PNPLA6 | patatin like domain 6, lysophospholipase | ORPHA:1173 |
| POU1F1 | POU class 1 homeobox 1 | ORPHA:95494 |
| PROKR2 | prokineticin receptor 2 | ORPHA:3157 |
| PROP1 | PROP paired-like homeobox 1 | ORPHA:95494 |
| RBM28 | RNA binding motif protein 28 | ORPHA:157954 |
| RNF216 | ring finger protein 216 | ORPHA:1173 |
| RNPC3 | RNA binding region (RNP1, RRM) containing 3 | ORPHA:231662 |
| SIM1 | SIM bHLH transcription factor 1 | ORPHA:398079 |
| SOX2 | SRY-box transcription factor 2 | ORPHA:3157 |
| SOX3 | SRY-box transcription factor 3 | ORPHA:3157 |
| TBX19 | T-box transcription factor 19 | ORPHA:199296 |
近两年的全球研究 197L2
2024/10 起在 Europe PMC 检索所得,按发表时间倒序显示最近 20 篇。标题未译成中文——自动翻译需要接入 LLM 服务,尚未引入。
- 2026-10开放获取Genetic landscape of a neonatal hypogonadotropic hypogonadism series: Novel variants and phenotypic spectrum
- 2026-09综述Current perspectives on the pharmacologic treatment of boys and adolescents with congenital hypogonadotropic hypogonadism
- 2026-09综述开放获取Application of Whole-Exome Sequencing in Identifying the Molecular Basis of Idiopathic Male Infertility
- 2026-09Comment on "Congenital Hypogonadotropic Hypogonadism with Anosmia and Gorlin Features Caused by a PTCH1 Mutation Reveals a New Candidate Gene for Kallmann Syndrome" (Barraud et al., Neuroendocrinology, 2021;111:99-114)
- 2026-09开放获取Identification and Functional Characteristics of <i>NR5A1</i> Gene Variant in Patients with 46,XY Disorders of Sex Development
- 2026-09病例报告开放获取Case Report: RYR1-related myopathy with hypoxic ischemic encephalopathy-a case of severe neonatal presentation due to a <i>de novo</i> variant of uncertain significance
- 2026-08开放获取Jacobs Syndrome Presenting With Delayed Puberty and Central Hypogonadism: A Rare Case Report
- 2026-08病例报告开放获取From Amenorrhea to Pregnancy: Comprehensive Management of GnRH Pulse Therapy Achieving Pregnancy in a Woman with Idiopathic Hypogonadotropic Hypogonadism
- 2026-08综述开放获取Incomplete male puberty: a new nosographic entity
- 2026-08开放获取Identification and prenatal diagnosis of a novel likely pathogenic ANOS1 variant in a large Chinese Kallmann syndrome family
- 2026-08开放获取Establishing the role of ZBTB20 mutations in GnRH deficiency and impaired neurogenesis in the subventricular zone: a human cohort and animal model study
- 2026-08病例报告Double heterozygous PROK2 p.(Ile55Ter)-PROKR2 p.(Arg85Leu) variants: case report of an oligogenic case of congenital hypogonadotropic hypogonadism with anosmia
- 2026-08开放获取Clinical features of androgen abuse withdrawal in men during the first year of cessation: a community dwelling study
- 2026-07开放获取Association Study Between <i>NOTCH2</i> Gene and Idiopathic Central Precocious Puberty in Korean Girls
- 2026-07病例报告开放获取Case Report of Initial Manifestation of Hypogonadotropic Hypogonadism Based on Unoccluded Growth Plates in a 26-Year-Old Vietnamese Patient
- 2026-07综述开放获取Micro-TESE in Non-Obstructive Azoospermia: Phenotype-Guided Hormonal Optimization and Testosterone Response-Prognostic Biomarker or Therapeutic Target?
- 2026-07开放获取The Spectrum of Congenital Hypogonadotropic Hypogonadism: A 30-Year Experience at a Tertiary Paediatric Centre
- 2026-07开放获取A Novel Hemizygous <i>ANOS1</i> Variant in a Patient With Kallmann Syndrome and Type 2 Diabetes Mellitus: A Case Report
- 2026-07综述开放获取Is Male Hypogonadism a Risk Factor for Cancer Through Weakening of the Immune System?
- 2026-07开放获取Single-nuclei RNA sequencing reveals heterogeneity within developing GnRH3 neurons in zebrafish
境外已获批用于本病的药物 0L2
欧盟与美国均未检索到已获批用于本病的药物。
尚未获批的在研药物(1 项)
这些药已被欧盟或美国的监管机构认定为罕见病用药(英文 orphan drug designation,中文行业里通称「孤儿药资格」——「孤儿」说的是这类药市场太小、没有厂商愿意认领,不是在说病人)。但这只是一种监管身份:意味着监管机构给予研发上的激励,不代表这个药已被证明有效,也不代表将来一定能上市,绝大多数最终不会成药。列在这里是为了看清有哪些方向正在被尝试。
- leuprorelin acetate欧盟2017-01-12Treatment of congenital hypogonadotropic hypogonadism官方记录
数据来自欧洲药品管理局(EMA)的药品与罕见病用药资格公开导出表,以及美国 FDA 的罕见病用药资格数据库(Orphan Drug Product Designation Database)。两边口径不同:欧盟一侧取的是当前状态仍为「已授权」的药品;美国一侧记录的是「曾获批准」这一事实,FDA 的公开表不追踪药物此后是否退市(例如 Relyvrio 于 2024 年撤市,表中仍记为已获批)。请以官方记录页为准。
在中国开展的临床试验 5L2
按病名在 ClinicalTrials.gov 检索、并校验研究中心含中国大陆而来。登记状态不等于现在真的能入组——务必按 NCT 号到原站核实,并与主治医生商量。
登记为可入组 1
- 尚未开始招募NCT06561594To Evaluate Recombinant Human Follicle Stimulating Hormone-CTP Fusion Protein Injection or Placebo Combined With Chorionic Gonadotropin for Injection中国研究中心 17 个:Beijing、Chengdu、Guangzhou、Hefei、Jining、Nanchang 等 12 地
其他状态的试验(4 项)
- 已完成NCT01403532Sequential Therapy for Hypogonadotropic Hypogonadism中国研究中心 1 个:Shanghai
- 状态未知NCT02880280Human Menopausal Gonadotropin Combining With Human Chorionic Gonadotropin Treat Congenital Hypogonadotropic Hypogonadism中国研究中心 1 个:Beijing
- 状态未知NCT03687606Efficacy and Safety of Long Term Use of hCG or hCG Plus hMG in Males With Isolated Hypogonadotropic Hypogonadism (IHH)中国研究中心 1 个:Wuhan
- 状态未知NCT05569577An Open Labeled RCT on the Effect of Additional hCG Injection for LPS on Pregnancy Outcomes in IHH Patients中国研究中心 2 个:Shanghai
中国境外的在招试验 4L2
这些试验在中国没有研究中心,通常无法直接报名——入组一般要求在当地居住并接受随访。列在这里是因为它另有用处:看清楚全世界正在试哪些药、做到了哪一期、由谁在做。把药名和 NCT 编号记下来去问主治医生,或据此进一步查该药是否已在境外获批、是否有拓展性用药(expanded access)通道。
共 5 项。
- 尚未开始招募NCT04252001Growing up With the Young Endocrine Support System (YESS!)比利时、荷兰、西班牙、英国
- 招募中NCT05896293Kisspeptin Administration Subcutaneously to Patients With IHH美国
- 招募中NCT01500447Inherited Reproductive Disorders美国
- 招募中NCT01601171Genetics of Reproductive Disorders (Including Kallmann Syndrome) and Cleft Lip and/or Palate瑞士
- 招募中NCT01793168Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford澳大利亚、美国
外部标识与链接
发现这一页有错误?告诉我 · 邮件主题会自动带上本页的 ORPHA 编号
本页数据来源
- 疾病定义、同义词、基因、表型、流行病学:Orphanet(CC BY 4.0)
- 中文病名:Orphanet 中文包,冻结于 2020-06-01
- 表型中文标签:HPO 简体中文翻译(CHPO 上游成果)